Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy

Purpose. To determine the immune response after dendritic cell (DC) vaccine and cytokine-induced killer cells (CIK) therapy and assess its associated toxicity, survival benefit, and changes in the quality of life (QOL) of advanced colorectal cancer (CRC) patients. Methods. We recruited 100 patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BioMed research international 2014-01, Vol.2014 (2014), p.1-5
Hauptverfasser:	Zhu, Hui, Yang, Xuejing, Li, Jiali, Ren, Yanjie, Zhang, Tianyu, Zhang, Chunze, Zhang, Jintai, Li, Jing, Pang, Yan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biomedical research Cancer therapies Cancer Vaccines - administration & dosage Cancer Vaccines - adverse effects Cancer Vaccines - immunology Care and treatment Cell- and Tissue-Based Therapy Cellular therapy Clinical Study Colorectal cancer Colorectal Neoplasms - genetics Colorectal Neoplasms - immunology Colorectal Neoplasms - pathology Colorectal Neoplasms - therapy Cytokine-Induced Killer Cells - immunology Cytokines Cytotoxicity Dendritic Cells - immunology Drug therapy Drug-Related Side Effects and Adverse Reactions Female Health aspects Humans Immune response Immune system Immunity, Cellular Immunotherapy Kaplan-Meier Estimate Male Medical prognosis Medicine Middle Aged Oncology Patient outcomes Physiological aspects Quality of Life Radiation therapy Surgery Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!